Category | Diagnostics

LabCorp has acquired Covance for $6.1 billion

Posted on 04 November 2014

Laboratory Corporation of America acquired Covance for $6.1 billion.

Tags: , ,

Qiagen and Astellas form a biotech partnership to develop companion diagnostics

Posted on 30 October 2014

QIAGEN announced a biotech partnership agreement with Astellas Pharma to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases.

Tags: , , ,

In m&a news: Optum has bought Alere Health for $600 million

Posted on 30 October 2014

In today’s m&a news, Optum buys Alere Health from Alere for $600 million.

Tags: , ,

Abbott announces acquisition of Topera for $250 million

Posted on 30 October 2014

Abbott has entered into an acquisition agreement to purchase Topera.

Tags: , ,

Molecular Devices and Roche form a biotech partnership for Nano-TRF assay

Posted on 29 October 2014

Molecular Devices has partnered with the Discovery Technologies team at the Roche announced a biotech partnership to develop a high-throughput detection system for drug discovery screens employing Roche’s proprietary Ruthenium-based nanosecond time resolved fluorescence (Nano-TRF) assays.

Tags: , , ,

Enigma raises $50 million from Chinese private financing

Posted on 23 October 2014

Enigma Diagnostics also announced it has signed a US$50 million subscription agreement with Chinese private equity fund.

Tags: ,

Pharmacyclics forms an pharma alliance with Roche

Posted on 17 October 2014

Pharmacyclics has entered into a pharma alliance agreement with Roche to evaluate the safety, tolerability and preliminary efficacy of IMBRUVICA (ibrutinib)in combination with GAZYVA (obinutuzumab).

Tags: , ,

Cardiorentis has established a pharma partnership with Roche

Posted on 17 October 2014

Cardiorentis announced a pharma partnership with Roche to establish the therapeutic efficacy and safety of Ularitide.

Tags: , , ,

Roche has acquired a cancer drug for $65.8 million

Posted on 15 October 2014

Roche has acquired from Wilex the rights to an undisclosed cancer drug for as much as $65.8 million.

Tags: , , ,

RPS gets $28 million in debt financing

Posted on 14 October 2014

RPS Diagnostics announced the closing of $28 million of non-dilutive debt financing with OrbiMed.

Tags: ,